Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GW Pharma receives FDA fast-track designation for Dravet syndrome treatment
GW Pharma receives FDA fast-track designation for Dravet syndrome treatment
GW Pharma receives FDA fast-track designation for Dravet syndrome treatment
Submitted by
admin
on June 6, 2014 - 10:07am
Source:
Reuters
News Tags:
FDA
GW Pharma
fast track
Dravet syndrome
Epidiolex
Headline:
GW Pharma receives FDA fast-track designation for Dravet syndrome treatment
Do Not Allow Advertisers to Use My Personal information
